Skip to main content
Premium Trial:

Request an Annual Quote

Mayo Clinic and IBM Forge Medical Informatics Collaboration; Includes Supercomputing for Molecular Disease Modeling

NEW YORK, Aug. 4 (GenomeWeb News) - IBM and the Mayo Clinic have forged a "broad collaboration to accelerate advances in patient care and research" using combined technologies, according to an official statement released today.


Under the collaboration, May Clinic will be the first medical institution to use IBM's Blue Gene supercomputer for "on demand" access to specialized algorithms for advancing Mayo's work in the molecular modeling of disease.


The partnership will also provide the ability to map patient records and link them to new medical information based on the fields of genomics, proteomics, and molecular modeling, the organizations said.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.